14-day Premium Trial Subscription Try For FreeTry Free
$3.12
-0.0600 (-1.89%)
At Close: May 02, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days $3.01 $5.59 Thursday, 2nd May 2024 NEXI stock ended at $3.12. This is 1.89% less than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 3.48% from a day low at $3.07 to a day high of $3.18.
90 days $3.01 $19.65
52 weeks $0.150 $28.69

Historical NexImmune, Inc. prices

Date Open High Low Close Volume
Sep 27, 2023 $0.210 $0.211 $0.195 $0.210 164 993
Sep 26, 2023 $0.200 $0.219 $0.190 $0.202 161 253
Sep 25, 2023 $0.202 $0.214 $0.192 $0.205 244 223
Sep 22, 2023 $0.200 $0.210 $0.195 $0.210 132 694
Sep 21, 2023 $0.200 $0.211 $0.199 $0.210 56 162
Sep 20, 2023 $0.245 $0.245 $0.200 $0.211 32 754
Sep 19, 2023 $0.213 $0.239 $0.200 $0.223 51 887
Sep 18, 2023 $0.270 $0.270 $0.216 $0.222 188 905
Sep 15, 2023 $0.200 $0.270 $0.195 $0.260 402 022
Sep 14, 2023 $0.195 $0.210 $0.195 $0.200 115 251
Sep 13, 2023 $0.205 $0.209 $0.195 $0.200 40 281
Sep 12, 2023 $0.200 $0.219 $0.200 $0.200 132 597
Sep 11, 2023 $0.210 $0.210 $0.195 $0.199 77 159
Sep 08, 2023 $0.215 $0.219 $0.201 $0.202 62 437
Sep 07, 2023 $0.217 $0.217 $0.205 $0.215 14 327
Sep 06, 2023 $0.220 $0.220 $0.205 $0.206 145 878
Sep 05, 2023 $0.201 $0.220 $0.201 $0.220 61 517
Sep 01, 2023 $0.210 $0.230 $0.206 $0.210 42 709
Aug 31, 2023 $0.216 $0.230 $0.201 $0.219 74 422
Aug 30, 2023 $0.222 $0.233 $0.222 $0.226 13 022
Aug 29, 2023 $0.205 $0.235 $0.201 $0.211 41 407
Aug 28, 2023 $0.205 $0.210 $0.204 $0.210 63 595
Aug 25, 2023 $0.230 $0.235 $0.201 $0.201 140 318
Aug 24, 2023 $0.244 $0.244 $0.230 $0.235 34 194
Aug 23, 2023 $0.240 $0.240 $0.230 $0.233 11 639
Click to get the best stock tips daily for free!

About NexImmune, Inc.

NexImmune. NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials f... NEXI Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT